Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Biomarkers : Section a of Disease Markers|November 20, 2018
High serum Hsp70 level predicts poor survival in colorectal cancer: Results obtained in an independent validation cohortLászló Gráf, Lóránd Barabás, Balázs Madaras, et al.
Thrombosis and Haemostasis|January 6, 2018
Platelet Count, ADAMTS13 Activity, von Willebrand Factor Level and Survival in Patients with Colorectal Cancer: 5-Year Follow-up StudyNóra Garam, Éva Maláti, György Sinkovits, et al.
Orvosi Hetilap|March 28, 2021
Hypercalcemia and renal insufficiency – where can we start?Nóra Garam, András Tislér, Ákos Pethő, et al.
International Journal of Cancer|August 10, 2017
Circulating mitochondrial stress 70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancerRitta Jubran, Judit Kocsis, Nóra Garam, et al.
Orvosi Hetilap|February 9, 2025
[CT segítségével/Localization of a small insulinoma with the aid of 68Ga-exendin PET/CT]Nóra Garam, Nikolette Szücs, Ildikó Tünde Bálint, et al.
Journal of Clinical Medicine|April 5, 2020
Sex Differences in Clinical Presentation and Outcomes among Patients with Complement-Gene-Variant-Mediated Thrombotic MicroangiopathyChristof Aigner, Martina Gaggl, Renate Kain, et al.
Frontiers in Immunology|March 13, 2019
Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic MicroangiopathiesEszter Trojnar, Mihály Józsi, Zsóka Szabó, et al.
Journal of Nephrology|February 18, 2021
Eculizumab use in a tertiary care nephrology center: data from the Vienna TMA cohortChristof Aigner, Martina Gaggl, Gunar Stemer, et al.
Clinical Kidney Journal|April 17, 2020
Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysisNóra Garam, Zoltán Prohászka, Ágnes Szilágyi, et al.
Pageof 2